LuCaS Decision Aid
BehavioralWeb-based Lung Cancer Screening Decision Aid
NCT Number: NCT02790866
This study evaluates the feasibility and acceptability of LuCaS Choices, a web-based decision aid designed to facilitate informed decision making about participation in lung cancer screening among individuals at high risk of lung cancer due to heavy cigarette smoking.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
University of Miami (FL), Miami, Florida, United States
The proposed project will develop an innovative web-based decision aid (DA) to improve decision making for lung cancer screening (LCS) among individuals at high risk for lung cancer due to cigarette smoking. Recent National Lung Screening Trial (NLST) data demonstrated a 20% relative reduction in lung cancer mortality for low dose computed tomography screening as compared to chest X-ray among individuals at high lung cancer risk. Given that lung cancer is the leading cause of cancer death in the United States with an estimated 160,340 deaths predicted for 2012, the new data have reinvigorated interest in LCS. However, LCS carries substantial risks including a high false positive rate, over-diagnosis, adverse psychosocial consequences, and increased radiation exposure. Further, it is unknown whether LCS would reduce lung cancer mortality among individuals who smoke but do not meet NLST eligibility criteria. Therefore, there is currently no clear best choice for whether a given individual should be screened or not. Decisions about participating in LCS should be well informed and consistent with individual preferences. However, previous data indicate that individuals who do undergo LCS rarely have a thorough understanding of the risks or benefits.
To address this rapidly emerging public health challenge, this research has developed a web-based decision aid (DA) to facilitate informed decision making regarding LCS in individuals at high risk for lung cancer (i.e., cigarette smokers), and will assess feasibility of DA administration and proposed methods for conducting a future randomized clinical trial (RCT) of DA effectiveness. The content of the DA will be based on the investigators previous studies exploring LCS decision making and other recent research.
The specific aim of the currently proposed research are to conduct a feasibility trial of the DA among individuals at high risk of lung cancer due to heavy cigarette smoking. Investigators will recruit participants to assess feasibility of: 1) delivering the DA intervention in a community setting, and 2) conducting research procedures and assessment tools as planned for a future RCT.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Web-based Lung Cancer Screening Decision Aid
NCI Website on Lung Cancer Screening
Time frame: Two Weeks (POST)
Percentage of participants who access LuCaS Choices or National Cancer Institute (NCI) website
Time frame: Two Weeks (POST)
Percentage of participants who would recommend LuCaS Choices or National Cancer Institute (NCI) website to others who want to learn more about lung cancer screening
Time frame: Two Weeks (POST)
Percentage of participants who indicated they were satisfied with LuCaS Choices or National Cancer Institute (NCI) website
Time frame: Two Weeks (POST)
Percentage of participants who wish to have continued access to LuCaS Choices or National Cancer Institute (NCI) website
Time frame: Two Weeks (POST)
Percentage of participants who complete the POST survey
Time frame: Four Months (FOL)
Percentage of participants who complete the FOL survey
Time frame: Four Months (FOL)
Percentage of participants who would recommend LuCaS Choices or National Cancer Institute (NCI) website to others who want to learn more about lung cancer screening
Time frame: Four Months (FOL)
Percentage of participants who indicated they were satisfied with LuCaS Choices or National Cancer Institute (NCI) website
Time frame: Four Months (FOL)
Percentage of participants who wish to have continued access to LuCaS Choices or National Cancer Institute (NCI) website
Time frame: Four Months (FOL)
Percentage of participants who access LuCaS Choices or National Cancer Institute (NCI) website
Time frame: Weekly from study initiation through 12 weeks
Number of individuals who make email or telephone contact to inquire about the study per week
Time frame: Weekly from study initiation through 12 weeks
Number of individuals who are determined to be study eligible
Time frame: Weekly from study initiation through 12 weeks
Number of individuals who provide informed consent per week
Jamie Studts
Other
Acronym: LuCaS-DA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05512377
Biliary Tract Cancer, Biliary Tract Diseases
Mobile, Alabama, United States
View Trial DetailsNCT07682220
Behavior, Digestive System Diseases
Harbin, Heilongjiang, China
View Trial DetailsNCT07682012
Bronchial Neoplasms, Carcinoma, Bronchogenic
Taipei, Taiwan
View Trial DetailsNCT02769962
Bronchial Neoplasms, Carcinoma
Bethesda, Maryland, United States
View Trial Details